We Know Who The Decision Makers Are

In addition to established relationships and superior access, reaching the decision makers at a busy meeting requires a qualified screening process. Talking to the right audience is critical to achieving meaningful results. Not all meeting attendees are decisions makers - and you don't want to leave this to "chance".

In 2005, 1 out of 2 hospital and clinical laboratory attendees were final decision makers or the final “selectors” .

Our prior surveys of Chicago meetings suggest that the mix will be different this year as it varies from city to city. Forty-four (44%) of the lab attendees are fresh each year (did not attend in the prior 3 years).

CaseBauer has surveyed over 5,000 meeting attendees since 1998. We have the industry's most comprehensive database on AACC attendees; including management/ budget/ and purchasing authority, as well as, systems in place, budgets, test volumes, and planned purchases.

We know, for example, that the United States attendance is skewed toward larger institutions. Forty-three percent (43%) of US hospital attendees were from hospitals with 500 beds or more (top 7% largest hospitals). Twenty-three percent (23%) were hospitals with more than 700 beds (not shown). The average bed size of attendees’ hospitals was 474 in 2005 .

We also know that twenty-five percent (25%) of lab attendees were not members of either the AACC, ASCP, or CLMA. Single memberships were most prevalent at 48% for AACC, 19% of ASCP, and 2% of CLMA. Joint AACC/CLMA memberships were held by 5% of lab attendees .

Seventy-six percent (76%) of attendees planned to attend only the AACC meeting in 2005 . Only seven percent (7%) of all lab attendees planned to attend both the AACC and CLMA.

In short, we know how many of the 19,000 meeting attendees are from Clinical Laboratories, Group Purchasing Organizations or are Lab Consultants. We know who the Government/ Education/ Press, Industry Analysts, attendees and why they attend this meeting. We know who the OEM, Distributors, IVD/Pharma, and other Business to Business attendees are and why they attend this meeting.

We know the attendees at this meeting far better than anyone.